Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.69% | 5.94% | 27.04% | 25.73% | 22.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.69% | 5.94% | 27.04% | 25.73% | 22.91% |
| Cost of Revenue | -5.15% | -0.56% | 19.82% | 17.82% | -9.21% |
| Gross Profit | 1.40% | 9.08% | 30.54% | 29.61% | 47.36% |
| SG&A Expenses | -0.18% | -6.32% | 22.67% | 20.58% | 18.98% |
| Depreciation & Amortization | -0.90% | -2.08% | 2.51% | -1.85% | -0.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.84% | -4.00% | 19.61% | 17.44% | 4.11% |
| Operating Income | 6.85% | 54.55% | 64.84% | 60.99% | 236.92% |
| Income Before Tax | 27.27% | 0.87% | 51.52% | 586.07% | 152.48% |
| Income Tax Expenses | 68.20% | 360.67% | 16.19% | 1,658.16% | 381.68% |
| Earnings from Continuing Operations | 18.66% | -25.28% | 64.72% | 430.44% | 129.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.66% | -25.28% | 64.72% | 430.44% | 129.50% |
| EBIT | 6.85% | 54.55% | 64.84% | 60.99% | 236.92% |
| EBITDA | 4.52% | 34.44% | 41.44% | 40.64% | 104.98% |
| EPS Basic | 18.97% | -25.19% | 66.42% | 439.45% | 131.42% |
| Normalized Basic EPS | 8.69% | 58.69% | 61.33% | 125.20% | 193.50% |
| EPS Diluted | 18.18% | -26.17% | 66.67% | 436.89% | 131.58% |
| Normalized Diluted EPS | 7.91% | 57.47% | 61.51% | 126.50% | 196.77% |
| Average Basic Shares Outstanding | -0.26% | -0.11% | -1.02% | -1.70% | -0.82% |
| Average Diluted Shares Outstanding | 0.46% | 0.65% | -1.13% | -2.25% | -1.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |